These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31810907)

  • 1. Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
    Petrelli F; Ghidini M; Cabiddu M; Pezzica E; Corti D; Turati L; Costanzo A; Varricchio A; Ghidini A; Barni S; Tomasello G
    Anticancer Res; 2019 Dec; 39(12):6431-6441. PubMed ID: 31810907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis.
    Wang B; Li F; Zhou X; Ma Y; Fu W
    World J Surg Oncol; 2019 Oct; 17(1):169. PubMed ID: 31639018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.
    Toh JWT; Phan K; Reza F; Chapuis P; Spring KJ
    Int J Colorectal Dis; 2021 Aug; 36(8):1573-1596. PubMed ID: 33604737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
    Paulose RR; Ail DA; Biradar S; Vasudevan A; Sundaram KR
    Indian J Cancer; 2019; 56(4):302-308. PubMed ID: 31607697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
    Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
    Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsatellite instability in mismatch repair proficient colorectal cancer: clinical features and underlying molecular mechanisms.
    Xu Y; Liu K; Li C; Li M; Zhou X; Sun M; Zhang L; Wang S; Liu F; Xu Y
    EBioMedicine; 2024 May; 103():105142. PubMed ID: 38691939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of combined tumour-infiltrating lymphocytes and microsatellite instability status in colorectal cancer: a systematic review and network meta-analysis.
    Wankhede D; Yuan T; Kloor M; Halama N; Brenner H; Hoffmeister M
    Lancet Gastroenterol Hepatol; 2024 Jul; 9(7):609-619. PubMed ID: 38734024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.
    Des Guetz G; Schischmanoff O; Nicolas P; Perret GY; Morere JF; Uzzan B
    Eur J Cancer; 2009 Jul; 45(10):1890-6. PubMed ID: 19427194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Prognostic Role of Microsatellite Instability in Patients With Stage II Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Romiti A; Rulli E; Pilozzi E; Gerardi C; Roberto M; Legramandi L; Falcone R; Pacchetti I; Marchetti P; Floriani I
    Clin Colorectal Cancer; 2017 Jun; 16(2):e55-e59. PubMed ID: 27670891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
    Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
    Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
    Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
    Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
    J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
    Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T
    Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
    Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
    Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Long-Term Outcomes of Microsatellite Instability Status in an Asian Cohort of Sporadic Colorectal Cancers.
    Tan WJ; Hamzah JL; Acharyya S; Foo FJ; Lim KH; Tan IBH; Tang CL; Chew MH
    J Gastrointest Cancer; 2018 Sep; 49(3):311-318. PubMed ID: 28550452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature.
    Gkekas I; Novotny J; Pecen L; Strigård K; Palmqvist R; Gunnarsson U
    Anticancer Res; 2017 Dec; 37(12):6563-6574. PubMed ID: 29187431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis.
    Tomasello G; Ghidini M; Galassi B; Grossi F; Luciani A; Petrelli F
    Sci Rep; 2022 Jan; 12(1):1055. PubMed ID: 35058539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of microsatellite instability in colorectal cancer: a Swedish multi-center study.
    Rantanen P; Keränen A; Barot S; Ghazi S; Liljegren A; Nordenvall C; Lindblom A; Lindforss U
    Int J Colorectal Dis; 2023 Jul; 38(1):197. PubMed ID: 37458848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative pathway in colorectal carcinogenesis based on the mismatch repair system and p53 expression in Korean patients with sporadic colorectal cancer.
    Kim HR; Kim HC; Yun HR; Kim SH; Park CK; Cho YB; Yun SH; Lee WY; Chun HK
    Ann Surg Oncol; 2013 Nov; 20(12):4031-40. PubMed ID: 22732839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.